Safety, Pharmacokinetics (PK) of AKT and MEK Combination
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: GSK1120212|DRUG: GSK2141795
Sponsor: GlaxoSmithKline